ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RTWG Rtw Biotech Opportunities Ltd

116.00
0.00 (0.00%)
13 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rtw Biotech Opportunities Ltd LSE:RTWG London Ordinary Share GG00BKTRRM22 ORD NPV (GBP)
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 116.00 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
112.00 120.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty USD 4.17M USD -4.76M USD -0.0123 -125.20 447.98M
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 116.00 GBX

Rtw Biotech Opportunities (RTWG) Latest News

Rtw Biotech Opportunities (RTWG) Discussions and Chat

Rtw Biotech Opportunities Forums and Chat

Date Time Title Posts
17/4/202314:42RTW Venture Fund - interesting trade?-

Add a New Thread

Rtw Biotech Opportunities (RTWG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Rtw Biotech Opportunities (RTWG) Top Chat Posts

Top Posts
Posted at 13/11/2024 08:20 by Rtw Biotech Opportunities Daily Update
Rtw Biotech Opportunities Ltd is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker RTWG. The last closing price for Rtw Biotech Opportunities was 116p.
Rtw Biotech Opportunities currently has 386,186,512 shares in issue. The market capitalisation of Rtw Biotech Opportunities is £594,727,228.
Rtw Biotech Opportunities has a price to earnings ratio (PE ratio) of -125.20.
This morning RTWG shares opened at -
Posted at 17/4/2023 14:42 by tiredoldbroker
The announcement that investee company Prometheus Biosciences (Nasdaq RXDX)is to be acquired by Merck for $200/share helps make RTWG an interesting trade over the next few months. At 31 March 2023, RXDX traded around $110 and made up 14.8% of RTWG's NAV. Therefore, this deal adds around 12% to 31 March NAV which was $1.49/about 120p.

RTWG has a good long term record and has more often traded at or above NAV, I think. Looks to me like the current offer price of 96.8p is an interesting point to start a new holding.
Rtw Biotech Opportunities share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock